Skip to content

Evaluating antioxidant and anti-inflammatory effects and safety of rosemary/ginger extracts at different doses in healthy or high-risk subjects

Evaluating antioxidant and anti-inflammatory effects and safety of rosemary/ginger extracts at different doses in healthy or high-risk subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009408
Enrollment
72
Registered
2024-05-08
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Seoul National University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [Healthy group] 1) Agreement to participate in the study and sign an informed consent form 2) Men and women aged 40 years or older 3) Non-smokers 4) Subjects with a normal range of BMI and body fat perentage [High-risk group] 1) Agreement to participate in the study and sign an informed consent form 2) Men and women aged 40 years or older 3) Smokers 4) Subjects with a BMI and body fat percentage above overweight range 5) Subjects with a Recommended Food Score below the middle range

Exclusion criteria

Exclusion criteria: 1) Subjects with the following diseases: Chronic inflammatory diseases, diabetes, liver disease, kidney disease, cardiovascular disease, hypertension, etc. 2) Continued use of health functiona food or medicines or oriental medicines 3) a heavy drinker 4) Blood donation more than 500 mL within 3 months before the first visit 5) Participation in another clinical study within 1 month before the first visit 6) Pregnant or lactating women, or women planning to be pregnant 7) Hypersensitivity to the ingredients contained in the test·control food or experience of severe food allergic reactions 8) Any condition that the investigator considers inappropriate to participate in this study

Design outcomes

Primary

MeasureTime frame
Antioxidant and anti-inflammatory target biomarkers ;Metabolites (blood, urine)

Secondary

MeasureTime frame
Vital signs, adverse events

Countries

Korea, Republic of

Contacts

Public ContactYoon Ju Yeo

Global Medical Research Center

yj2551@gmrc.co.kr+82-70-8801-7081

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026